10.63 USD
↘ 3.52 (24.86%)PRE MARKET (AS OF 04:06 AM EST)
Shares of Summit Therapeutics Inc. Common Stock (SMMT) are trading at $10.63. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, SMMT trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Nov 13, 2026.